Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, April 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 4 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 308 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,164 followers.

@singhak_endo @AbdTahrani @ADA_DiabetesPro @American_Heart @drkevinfernando @kamleshkhunti @docwas @BrJCardiol @drpatrickholmes @DrDerekConnolly @DSNforumUK @AmDiabetesAssn @bananabeba Yes I think so https://t.co/vybPISUavC found no trials and minimal data

Reply Repost Favourite

Cochrane: Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of T2D https://t.co/Kd2x1embGS

Reply Repost Favourite

Cochrane: Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of T2D https://t.co/nyFy3g1Pxf

Reply Repost Favourite

Cochrane: Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of T2D https://t.co/RUe651s37G

Reply Repost Favourite